Search research articles
Contact Us
Filters
Showing results (81-90 of 155) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2010
Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12
Christine J Harrison, Robert K Hills, Anthony V Moorman, et al.
Blood
|
April 30, 2011
Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia
Vikki Rand, Helen Parker, Lisa J Russell, et al.
Genes, Chromosomes & Cancer
|
December 30, 2016
Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia
Lisa J Russell, Lisa Jones, Amir Enshaei, et al.
Leukemia & Lymphoma
|
October 22, 2022
Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia
Richard Gallon, Rachel Phelps, Leigh Betts, et al.
Nature
|
August 6, 2025
Excised DNA circles from V(D)J recombination promote relapsed leukaemia
Zeqian Gao, James N F Scott, Matthew P Edwards, et al.
British Journal of Haematology
|
December 12, 2025
Benchmarking the paediatric T-cell ALL subtype classifier, TALLSorts
Ozcan Gulbey, Terena James, Ruth E Cranston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2014
IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome
Lisa J Russell, Amir Enshaei, Lisa Jones, et al.
Haematologica
|
February 25, 2021
The <i>EBF1-PDGFRB</i> T681I mutation is highly resistant to imatinib and dasatinib <i>in vitro</i> and detectable in clinical samples prior to treatment
Thai Hoa Tran, Jonathan V Nguyen, Adrian Stecula, et al.
The Lancet. Haematology
|
March 31, 2022
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial
David I Marks, Laura Clifton-Hadley, Mhairi Copland, et al.
Leukemia
|
March 1, 2019
SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain
Paul B Sinclair, Sarra Ryan, Matthew Bashton, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 155) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2010
Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12
Christine J Harrison, Robert K Hills, Anthony V Moorman, et al.
Blood
|
April 30, 2011
Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia
Vikki Rand, Helen Parker, Lisa J Russell, et al.
Genes, Chromosomes & Cancer
|
December 30, 2016
Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia
Lisa J Russell, Lisa Jones, Amir Enshaei, et al.
Leukemia & Lymphoma
|
October 22, 2022
Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia
Richard Gallon, Rachel Phelps, Leigh Betts, et al.
Nature
|
August 6, 2025
Excised DNA circles from V(D)J recombination promote relapsed leukaemia
Zeqian Gao, James N F Scott, Matthew P Edwards, et al.
British Journal of Haematology
|
December 12, 2025
Benchmarking the paediatric T-cell ALL subtype classifier, TALLSorts
Ozcan Gulbey, Terena James, Ruth E Cranston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2014
IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome
Lisa J Russell, Amir Enshaei, Lisa Jones, et al.
Haematologica
|
February 25, 2021
The <i>EBF1-PDGFRB</i> T681I mutation is highly resistant to imatinib and dasatinib <i>in vitro</i> and detectable in clinical samples prior to treatment
Thai Hoa Tran, Jonathan V Nguyen, Adrian Stecula, et al.
The Lancet. Haematology
|
March 31, 2022
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial
David I Marks, Laura Clifton-Hadley, Mhairi Copland, et al.
Leukemia
|
March 1, 2019
SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain
Paul B Sinclair, Sarra Ryan, Matthew Bashton, et al.
Page
of 16